BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $951,283 | -10.0% | 134,362 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $1,056,670 | +181.0% | 126,699 | +256.2% | 0.00% | +100.0% |
| Q2 2022 | $376,000 | -97.9% | 35,574 | -96.7% | 0.00% | -97.0% |
| Q1 2022 | $17,656,000 | +849.2% | 1,085,846 | +493.7% | 0.03% | +266.7% |
| Q1 2021 | $1,860,000 | +678.2% | 182,905 | +263.8% | 0.01% | +350.0% |
| Q2 2020 | $239,000 | +67.1% | 50,277 | -29.8% | 0.00% | +100.0% |
| Q1 2020 | $143,000 | -94.9% | 71,660 | -67.2% | 0.00% | -97.6% |
| Q2 2014 | $2,785,000 | – | 218,413 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |